This randomized pilot clinical trial studies the side effects and best dose of naloxegol and
to see how well it works in treating patients with stage IIIB-IV non-small cell lung cancer.
Naloxegol may relieve some of the side effects of opioid pain medication and fight off future
growth in the cancer.
Intervention
Laboratory Biomarker Analysis, Naloxegol, Placebo, Quality-of-Life Assessment
Condition
Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
Investigators
Pankaj Gupta, MD